01923nas a2200205   4500008004100000022001400041245009100055210006900146260004200215300000900257490000600266520128800272653002401560653001801584653001001602653002201612653002001634100002601654856003701680       2018                        eng d  a1927-032100aThe Dynamics of Knowledge Sharing in the Biotechnology Industry: An Indian Perspective0 aDynamics of Knowledge Sharing in the Biotechnology Industry An I  aOttawabTalent First Networkc01/2018  a5-150 v83 aThe role of biotechnology in providing an alternate, more productive approach to new drug development is well accepted globally. Multinational pharmaceutical companies have begun outsourcing product development and its clinical validation to biotechnology firms in India. The sector in India has also witnessed the entry of startups in various phases of the drug development value chain. Technological innovation is a key growth driver in the “bio pharma” vertical in recognition of which numerous alliances are seen in the sector in India. These alliances have put in place a structure for technological learning to happen, which is necessary for innovation. However, the nature of knowledge in biotechnology, in large measure, is both tacit and complex. Such knowledge is difficult to transfer. At the same time, transferability of knowledge is critical to developing technological capability, which in turn can facilitate the technological innovations that are crucial for the growth of the sector in India. The current research is motivated by the question of how the firms in this sector deal with this paradox. An exploratory approach is adopted to understand the practices of knowledge sharing as well as its perceived impediments at the firm level in the Indian context. 10aabsorptive capacity10abiotechnology10aIndia10aknowledge sharing10atacit knowledge1 aJoshi, Tripurasundari  uhttp://timreview.ca/article/112900766nas a2200253   4500008004100000022001400041245007500055210006900130260004200199300000800241490000600249653001800255653002600273653001800299653002100317653002500338653001700363653002000380100001800400700002300418700001700441700001700458856003700475       2018                        eng d  a1927-032100aEditorial: Inclusive Innovation in Developed Countries (February 2018)0 aEditorial Inclusive Innovation in Developed Countries February 2  aOttawabTalent First Networkc02/2018  a3-60 v810abiotechnology10aconvergent innovation10afood security10ainclusive growth10ainclusive innovation10amaker spaces10aOpen innovation1 aMcPhee, Chris1 aSchillo, R. Sandra1 aEarl, Louise1 aKinder, Jeff  uhttp://timreview.ca/article/113401419nas a2200265   4500008004100000022001400041245007900055210006900134260004200203300001000245490000600255520066500261653002100926653001500947653001800962653001700980653002500997653001501022653000801037653001501045653002001060100002001080700001601100856003701116       2018                        eng d  a1927-032100aInclusive Innovation in Biohacker Spaces: The Role of Systems and Networks0 aInclusive Innovation in Biohacker Spaces The Role of Systems and  aOttawabTalent First Networkc02/2018  a27-370 v83 aIn this article, we examine the development of biohacker spaces and their impact on innovation systems through the lens of inclusive innovation. Examining issues associated with people, activities, outcomes, and governance, we observe that biohacker spaces offer an alternative approach to biotechnological research outside the orthodox walls of academia, industry, and government. We explain that harnessing the full innovative potential of these spaces depends on flexible legal and regulatory systems, including appropriate biosafety regulations and intellectual property policies and practices, and organic, community-based social and financial networking.10abiohacker spaces10abiohacking10abiotechnology10acrowdfunding10ainclusive innovation10ainnovation10alaw10aregulation10asocial networks1 ade Beer, Jeremy1 aJain, Vipal  uhttp://timreview.ca/article/113701258nas a2200217   4500008004100000022001400041245008800055210006900143260004200212300001000254490000600264520060500270653001200875653001800887653002000905653002000925653000800945653002700953100002400980856003601004       2013                        eng d  a1927-032100aStrategic Partnerships and Open Innovation in the Biotechnology Industry in Belgium0 aStrategic Partnerships and Open Innovation in the Biotechnology   aOttawabTalent First Networkc04/2013  a23-280 v33 aStrategic partnerships in the biotechnology industry allow new technology-based firms to gain a foothold in this high-cost, high-risk industry. In this article, we examine the impact of strategic partnerships and open innovation on the success of new biotechnology firms in Belgium by developing multiple case studies of firms in regional biotechnology clusters. We find that, despite their small size and relative immaturity, new biotechnology firms are able to adopt innovative business models by providing R&D and services to larger firms and openly cooperating with them through open innovation. 10aBelgium10abiotechnology10abusiness models10aOpen innovation10aR&D10astrategic partnerships1 aSegers, Jean-Pierre  uhttp://timreview.ca/article/676